A Small Peptide Increases Drug Delivery in Human Melanoma Cells

Melanoma is the most fatal type of skin cancer and is notoriously resistant to chemotherapies. The response of melanoma to current treatments is difficult to predict. To combat these challenges, in this study, we utilize a small peptide to increase drug delivery to melanoma cells. A peptide library...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Shirley, Darwish, Shaban, Ariani, Hanieh Hossein Nejad, Lozada, Kate Alison, Salehi, David, Cinelli, Maris A., Silverman, Richard B., Kaur, Kamaljit, Yang, Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145755/
https://www.ncbi.nlm.nih.gov/pubmed/35631623
http://dx.doi.org/10.3390/pharmaceutics14051036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145755/
https://www.ncbi.nlm.nih.gov/pubmed/35631623
http://dx.doi.org/10.3390/pharmaceutics14051036

Ejemplares similares